Effektivnost' nizkikh doz gemtsitabina v kombinatsii s tsisplatinom v lechenii disseminirovannogo raka molochnoy zhelezy s progressirovaniem posle primeneniya antratsiklinov, taksanov i kapetsitabina
- 作者: Semiglazova T.Y.1, Gershanovich M.L.1, Latipova D.K.1, Filatova L.V.1, Chubenko V.A.1, Semiglazov V.V.1, Matsko D.E.1, Klimenko V.V.1
-
隶属关系:
- 期: 编号 8 (2012)
- 页面: 61-67
- 栏目: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279565
- ID: 279565
如何引用文章
详细
全文:
作者简介
Tat'yana Semiglazova
Email: tsemiglazova@mail.ru
Mikhail Gershanovich
Email: gershanovich@yandex.ru
Dilorom Latipova
Email: dilat77@mail.ru
Larisa Filatova
Email: Larisa_Filatova@list.ru
Vyacheslav Chubenko
Email: vchubenko@me.com
Vladislav Semiglazov
Email: ssemiglazov@mail.ru
Dmitriy Matsko
Veronika Klimenko
Email: veronika30081987@mail.ru
参考
- Nagorney RA, Link J, Blitzer J, et al. Gemcitabine plus cisplatin repainting doublet therapy in previously treated, relapsed breast cancer patient. J Clin Oncol 2000;18(11):2245-49.
- Heinemann V, Stemmler HJ, Wohlrab A, et al. High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer. Cancer Chemother Pharmacol 2006;57(5):640-46.
- Fuentes H, Galderillo G, Alexander F, et al. Phase II study of gemcitabine plus cisplatin in metastatic breast cancer. Anticancer Drugs 2006;17(5):565-70.
- Seo J, Oh S, Choi C, et al. Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer. Cancer Chemother Pharmacol 2007;59(2):269-74.
- Sanchez-Escribano Morcuende R, Ales-Martinez J, Aramburo Gonzalez P. Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens. Clin Transl Oncol 2007;9(7):459-64.
- Tas F, Guney N, Derin D, et al. Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer. Invest New Drugs 2008;26(4):363-68.
- Kim G, Oh S, Kwon H, et al. Phase II study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer. Cancer Res Treat 2008;40(3):101-05.
- Chew H, Doroshow J, Frankel P, et al. Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer. J Clin Oncol 2009;27(13):2163-69.
- Somali I, Alacacioglu A, Tarhan M, et al. Cisplatin plus gemcitabine chemotherapy in taxane/ anthracycline-resistant metastatic breast cancer. Chemotherapy 2009;55(3):155-60.
- Chan S, Romieu G, Huober J, et al. Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. J Clin Oncol 2009;27(11):1753-60.
- Shehata S, Saad E, Goda Y, et al. A phase II study of gemcitabine combined with vinorel-bine as first-line chemotherapy for metastatic breast cancer. Hematol Oncol Stem Sell Ther 2010;3(1):1-6.
- Malmstrom A, Hansen J, Malmberg L, et al. Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pretreated breast cancer patients: A phase II study. Acta Oncol 2010;49(1):35-41.
- Yardley D, Burris H, Hanson S, et al. Weekly gemcitabine and trastuzumab in the treatment of patients with HER2- overexpressing metastatic breast cancer. Clin Breast Cancer 2009;9(3):178-83.
- O'Shaughnessy J, Osborne C, Pippen JE, et al. Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer. N Engl J Med 2011;364:205-14.